omega-n-methylarginine has been researched along with 1,3-dimethylthiourea in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (1,3-dimethylthiourea) | Trials (1,3-dimethylthiourea) | Recent Studies (post-2010) (1,3-dimethylthiourea) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 457 | 0 | 52 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, A; Sendo, F; Uchida, T; Yamashita, T | 1 |
| Mayhan, WG; Patel, KP | 1 |
2 other study(ies) available for omega-n-methylarginine and 1,3-dimethylthiourea
| Article | Year |
|---|---|
Nitric oxide is an effector molecule in inhibition of tumor cell growth by rIFN-gamma-activated rat neutrophils.
Topics: Animals; Catalase; Cell Division; Cytotoxicity Tests, Immunologic; Enzyme Inhibitors; Free Radical Scavengers; Interferon-gamma; Male; Neutrophil Activation; Neutrophils; Nitric Oxide; omega-N-Methylarginine; Oxyhemoglobins; Rats; Recombinant Proteins; Superoxide Dismutase; Thiourea; Tumor Cells, Cultured | 1997 |
Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus.
Topics: Acetylcholine; Animals; Basilar Artery; Diabetes Mellitus, Experimental; Free Radical Scavengers; Male; Nitric Oxide Synthase; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Streptozocin; Substance P; Thiourea; Vasodilation; Vasodilator Agents | 1998 |